                         SEQUENCE LISTING

<110>  Gradalis, Inc.
       Nemunaitis, John
       Rao, John
 
<120>  COMPOSITIONS AND METHODS FOR TREATING PROSTATE CANCER

<130>  GRAD:1035

<150>  US Provisional Patent Application 61532403
<151>  2011-09-08

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  4314
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  1
cgagatcccg gggagccagc ttgctgggag agcgggacgg tccggagcaa gcccagaggc       60

agaggaggcg acagagggaa aaagggccga gctagccgct ccagtgctgt acaggagccg      120

aagggacgca ccacgccagc cccagcccgg ctccagcgac agccaacgcc tcttgcagcg      180

cggcggcttc gaagccgccg cccggagctg ccctttcctc ttcggtgaag tttttaaaag      240

ctgctaaaga ctcggaggaa gcaaggaaag tgcctggtag gactgacggc tgcctttgtc      300

ctcctcctct ccaccccgcc tccccccacc ctgccttccc cccctccccc gtcttctctc      360

ccgcagctgc ctcagtcggc tactctcagc caacccccct caccaccctt ctccccaccc      420

gcccccccgc ccccgtcggc ccagcgctgc cagcccgagt ttgcagagag gtaactccct      480

ttggctgcga gcgggcgagc tagctgcaca ttgcaaagaa ggctcttagg agccaggcga      540

ctggggagcg gcttcagcac tgcagccacg acccgcctgg ttaggctgca cgcggagaga      600

accctctgtt ttcccccact ctctctccac ctcctcctgc cttccccacc ccgagtgcgg      660

agccagagat caaaagatga aaaggcagtc aggtcttcag tagccaaaaa acaaaacaaa      720

caaaaacaaa aaagccgaaa taaaagaaaa agataataac tcagttctta tttgcaccta      780

cttcagtgga cactgaattt ggaaggtgga ggattttgtt tttttctttt aagatctggg      840

catcttttga atctaccctt caagtattaa gagacagact gtgagcctag cagggcagat      900

cttgtccacc gtgtgtcttc ttctgcacga gactttgagg ctgtcagagc gctttttgcg      960

tggttgctcc cgcaagtttc cttctctgga gcttcccgca ggtgggcagc tagctgcagc     1020

gactaccgca tcatcacagc ctgttgaact cttctgagca agagaagggg aggcggggta     1080

agggaagtag gtggaagatt cagccaagct caaggatgga agtgcagtta gggctgggaa     1140

gggtctaccc tcggccgccg tccaagacct accgaggagc tttccagaat ctgttccaga     1200

gcgtgcgcga agtgatccag aacccgggcc ccaggcaccc agaggccgcg agcgcagcac     1260

ctcccggcgc cagtttgctg ctgctgcagc agcagcagca gcagcagcag cagcagcagc     1320

agcagcagca gcagcagcag cagcagcagc agcaagagac tagccccagg cagcagcagc     1380

agcagcaggg tgaggatggt tctccccaag cccatcgtag aggccccaca ggctacctgg     1440

tcctggatga ggaacagcaa ccttcacagc cgcagtcggc cctggagtgc caccccgaga     1500

gaggttgcgt cccagagcct ggagccgccg tggccgccag caaggggctg ccgcagcagc     1560

tgccagcacc tccggacgag gatgactcag ctgccccatc cacgttgtcc ctgctgggcc     1620

ccactttccc cggcttaagc agctgctccg ctgaccttaa agacatcctg agcgaggcca     1680

gcaccatgca actccttcag caacagcagc aggaagcagt atccgaaggc agcagcagcg     1740

ggagagcgag ggaggcctcg ggggctccca cttcctccaa ggacaattac ttagggggca     1800

cttcgaccat ttctgacaac gccaaggagt tgtgtaaggc agtgtcggtg tccatgggcc     1860

tgggtgtgga ggcgttggag catctgagtc caggggaaca gcttcggggg gattgcatgt     1920

acgccccact tttgggagtt ccacccgctg tgcgtcccac tccttgtgcc ccattggccg     1980

aatgcaaagg ttctctgcta gacgacagcg caggcaagag cactgaagat actgctgagt     2040

attccccttt caagggaggt tacaccaaag ggctagaagg cgagagccta ggctgctctg     2100

gcagcgctgc agcagggagc tccgggacac ttgaactgcc gtctaccctg tctctctaca     2160

agtccggagc actggacgag gcagctgcgt accagagtcg cgactactac aactttccac     2220

tggctctggc cggaccgccg ccccctccgc cgcctcccca tccccacgct cgcatcaagc     2280

tggagaaccc gctggactac ggcagcgcct gggcggctgc ggcggcgcag tgccgctatg     2340

gggacctggc gagcctgcat ggcgcgggtg cagcgggacc cggttctggg tcaccctcag     2400

ccgccgcttc ctcatcctgg cacactctct tcacagccga agaaggccag ttgtatggac     2460

cgtgtggtgg tggtgggggt ggtggcggcg gcggcggcgg cggcggcggc ggcggcggcg     2520

gcggcggcgg cggcgaggcg ggagctgtag ccccctacgg ctacactcgg ccccctcagg     2580

ggctggcggg ccaggaaagc gacttcaccg cacctgatgt gtggtaccct ggcggcatgg     2640

tgagcagagt gccctatccc agtcccactt gtgtcaaaag cgaaatgggc ccctggatgg     2700

atagctactc cggaccttac ggggacatgc gtttggagac tgccagggac catgttttgc     2760

ccattgacta ttactttcca ccccagaaga cctgcctgat ctgtggagat gaagcttctg     2820

ggtgtcacta tggagctctc acatgtggaa gctgcaaggt cttcttcaaa agagccgctg     2880

aagggaaaca gaagtacctg tgcgccagca gaaatgattg cactattgat aaattccgaa     2940

ggaaaaattg tccatcttgt cgtcttcgga aatgttatga agcagggatg actctgggag     3000

cccggaagct gaagaaactt ggtaatctga aactacagga ggaaggagag gcttccagca     3060

ccaccagccc cactgaggag acaacccaga agctgacagt gtcacacatt gaaggctatg     3120

aatgtcagcc catctttctg aatgtcctgg aagccattga gccaggtgta gtgtgtgctg     3180

gacacgacaa caaccagccc gactcctttg cagccttgct ctctagcctc aatgaactgg     3240

gagagagaca gcttgtacac gtggtcaagt gggccaaggc cttgcctggc ttccgcaact     3300

tacacgtgga cgaccagatg gctgtcattc agtactcctg gatggggctc atggtgtttg     3360

ccatgggctg gcgatccttc accaatgtca actccaggat gctctacttc gcccctgatc     3420

tggttttcaa tgagtaccgc atgcacaagt cccggatgta cagccagtgt gtccgaatga     3480

ggcacctctc tcaagagttt ggatggctcc aaatcacccc ccaggaattc ctgtgcatga     3540

aagcactgct actcttcagc attattccag tggatgggct gaaaaatcaa aaattctttg     3600

atgaacttcg aatgaactac atcaaggaac tcgatcgtat cattgcatgc aaaagaaaaa     3660

atcccacatc ctgctcaaga cgcttctacc agctcaccaa gctcctggac tccgtgcagc     3720

ctattgcgag agagctgcat cagttcactt ttgacctgct aatcaagtca cacatggtga     3780

gcgtggactt tccggaaatg atggcagaga tcatctctgt gcaagtgccc aagatccttt     3840

ctgggaaagt caagcccatc tatttccaca cccagtgaag cattggaaac cctatttccc     3900

caccccagct catgccccct ttcagatgtc ttctgcctgt tataactctg cactactcct     3960

ctgcagtgcc ttggggaatt tcctctattg atgtacagtc tgtcatgaac atgttcctga     4020

attctatttg ctgggctttt tttttctctt tctctccttt ctttttcttc ttccctccct     4080

atctaaccct cccatggcac cttcagactt tgcttcccat tgtggctcct atctgtgttt     4140

tgaatggtgt tgtatgcctt taaatctgtg atgatcctca tatggcccag tgtcaagttg     4200

tgcttgttta cagcactact ctgtgccagc cacacaaacg tttacttatc ttatgccacg     4260

ggaagtttag agagctaaga ttatctgggg aaatcaaaac aaaaacaagc aaac           4314


<210>  2
<211>  19
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  2
cagaaatgat tgcactatt                                                    19


<210>  3
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  3
aatagtgcaa tcatttctg                                                    19


<210>  4
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
cagcctgttg aactcttct                                                    19


<210>  5
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
agaagagttc aacaggctg                                                    19


<210>  6
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
acgaggcagc tgcgtacca                                                    19


<210>  7
<211>  19
<212>  DNA
<213>  artificial sequence

<220>
<223>  shynthetic oligonucleotide

<400>  7
tggtacgcag ctgcctcgt                                                    19


<210>  8
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  8
gcaggaagca gtatccgaa                                                    19


<210>  9
<211>  19
<212>  DNA
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  9
ttcggatact gcttcctgc                                                    19


<210>  10
<211>  245
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  10
tcgactgctg ttgaagtgag cgcccagaaa tgattgcact atttagtgaa gccacagatg       60

taaatagtgc aatcatttct ggttgcctac tgcctcggaa gcagctcact acattactca      120

gctgttgaag tgagcgccca gaaatgtcag caccatttag tgaagccaca gatgtaaata      180

gtgcaatcat ttctggttgc ctactgcctc ggaagcttaa taaaggatct tttattttca      240

ttggc                                                                  245


<210>  11
<211>  245
<212>  DNA
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  11
tcgactgctg ttgaagtgag cgcccagcct gttgaactct tcttagtgaa gccacagatg       60

taagaagagt tcaacaggct ggttgcctac tgcctcggaa gcagctcact acattactca      120

gctgttgaag tgagcgccca gcctgtatca ctattcttag tgaagccaca gatgtaagaa      180

gagttcaaca ggctggttgc ctactgcctc ggaagcttaa taaaggatct tttattttca      240

ttggc                                                                  245


<210>  12
<211>  245
<212>  DNA
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  12
tcgactgctg ttgaagtgag cgccacgagg cagctgcgta ccatagtgaa gccacagatg       60

tatggtacgc agctgcctcg tgttgcctac tgcctcggaa gcagctcact acattactca      120

gctgttgaag tgagcgccac gaggcactag cgtatcatag tgaagccaca gatgtatggt      180

acgcagctgc ctcgtgttgc ctactgcctc ggaagcttaa taaaggatct tttattttca      240

ttggc                                                                  245


<210>  13
<211>  245
<212>  DNA
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  13
tcgactgctg ttgaagtgag cgccgcagga agcagtatcc gaatagtgaa gccacagatg       60

tattcggata ctgcttcctg cgttgcctac tgcctcggaa gcagctcact acattactca      120

gctgttgaag tgagcgccgc aggaagttct atcagaatag tgaagccaca gatgtattcg      180

gatactgctt cctgcgttgc ctactgcctc ggaagcttaa taaaggatct tttattttca      240

ttggc                                                                  245


<210>  14
<211>  102
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  14

Met Ala Pro Asn Gln Leu Arg Leu Gln Leu Gln Gln Arg Leu Gln Gly 
1               5                   10                  15      


Gln Gln Gln Leu Ile His Gln Asn Arg Gln Ala Ile Leu Asn Gln Phe 
            20                  25                  30          


Ala Ala Thr Ala Pro Val Gly Ile Asn Met Arg Ser Gly Met Gln Gln 
        35                  40                  45              


Gln Ile Thr Pro Gln Pro Pro Leu Asn Ala Gln Met Leu Ala Gln Arg 
    50                  55                  60                  


Gln Arg Glu Leu Tyr Ser Gln Gln His Arg Gln Arg Gln Leu Ile Gln 
65                  70                  75                  80  


Gln Gln Arg Ala Met Leu Met Arg Gln Gln Ser Phe Gly Asn Asn Leu 
                85                  90                  95      


Pro Pro Ser Ser Gly Leu 
            100         


<210>  15
<211>  309
<212>  DNA
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  15
atggcaccta accagcttcg acttcaacta cagcagcgat tacagggaca acagcagttg       60

atacaccaaa atcggcaagc tatcttaaac cagtttgcag caactgctcc tgttggcatc      120

aatatgagat caggcatgca acagcaaatt acacctcagc cacccctgaa tgctcaaatg      180

ttggcacaac gtcagcggga actgtacagt caacagcacc gacagaggca gctaatacag      240

cagcaaagag ccatgcttat gaggcagcaa agctttggga acaacctccc tccctcatct      300

ggactatag                                                              309


<210>  16
<211>  192
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  16

Met Ala Pro Asn Gln Leu Arg Leu Gln Leu Gln Gln Arg Leu Gln Gly 
1               5                   10                  15      


Gln Gln Gln Leu Ile His Gln Asn Arg Gln Ala Ile Leu Asn Gln Phe 
            20                  25                  30          


Ala Ala Thr Ala Pro Val Gly Ile Asn Met Arg Ser Gly Met Gln Gln 
        35                  40                  45              


Gln Ile Thr Pro Gln Pro Pro Leu Asn Ala Gln Met Leu Ala Gln Arg 
    50                  55                  60                  


Gln Arg Glu Leu Tyr Ser Gln Gln His Arg Gln Arg Gln Leu Ile Gln 
65                  70                  75                  80  


Gln Gln Arg Ala Met Leu Met Arg Gln Gln Ser Phe Gly Asn Asn Leu 
                85                  90                  95      


Pro Pro Ser Ser Gly Leu Pro Val Gln Met Gly Asn Pro Arg Leu Pro 
            100                 105                 110         


Gln Gly Ala Pro Gln Gln Phe Pro Tyr Pro Pro Asn Tyr Gly Thr Asn 
        115                 120                 125             


Pro Gly Thr Pro Pro Ala Ser Thr Ser Pro Phe Ser Gln Leu Ala Ala 
    130                 135                 140                 


Asn Pro Glu Ala Ser Leu Ala Asn Arg Asn Ser Met Val Ser Arg Gly 
145                 150                 155                 160 


Met Thr Gly Asn Ile Gly Gly Gln Phe Gly Thr Gly Ile Asn Pro Gln 
                165                 170                 175     


Met Gln Gln Asn Val Phe Gln Tyr Pro Gly Ala Gly Met Val Pro Gln 
            180                 185                 190         


<210>  17
<211>  579
<212>  DNA
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  17
atggcaccta accagcttcg acttcaacta cagcagcgat tacagggaca acagcagttg       60

atacaccaaa atcggcaagc tatcttaaac cagtttgcag caactgctcc tgttggcatc      120

aatatgagat caggcatgca acagcaaatt acacctcagc cacccctgaa tgctcaaatg      180

ttggcacaac gtcagcggga actgtacagt caacagcacc gacagaggca gctaatacag      240

cagcaaagag ccatgcttat gaggcagcaa agctttggga acaacctccc tccctcatct      300

ggactaccag ttcaaatggg gaacccccgt cttcctcagg gtgctccaca gcaattcccc      360

tatccaccaa actatggtac aaatccagga accccacctg cttctaccag cccgttttca      420

caactagcag caaatcctga agcatccttg gccaaccgca acagcatggt gagcagaggc      480

atgacaggaa acataggagg acagtttggc actggaatca atcctcagat gcagcagaat      540

gtcttccagt atccaggagc aggaatggtt ccccaatag                             579


<210>  18
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  18

Asp Asp Leu Pro Arg Arg Arg Gly Arg Ser 
1               5                   10  


<210>  19
<211>  112
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  19

Met Asp Asp Leu Pro Arg Arg Arg Gly Arg Ser Ala Pro Asn Gln Leu 
1               5                   10                  15      


Arg Leu Gln Leu Gln Gln Arg Leu Gln Gly Gln Gln Gln Leu Ile His 
            20                  25                  30          


Gln Asn Arg Gln Ala Ile Leu Asn Gln Phe Ala Ala Thr Ala Pro Val 
        35                  40                  45              


Gly Ile Asn Met Arg Ser Gly Met Gln Gln Gln Ile Thr Pro Gln Pro 
    50                  55                  60                  


Pro Leu Asn Ala Gln Met Leu Ala Gln Arg Gln Arg Glu Leu Tyr Ser 
65                  70                  75                  80  


Gln Gln His Arg Gln Arg Gln Leu Ile Gln Gln Gln Arg Ala Met Leu 
                85                  90                  95      


Met Arg Gln Gln Ser Phe Gly Asn Asn Leu Pro Pro Ser Ser Gly Leu 
            100                 105                 110         


<210>  20
<211>  339
<212>  DNA
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  20
atggacgacc tgcccagaag aagaggcaga tccgcaccta accagcttcg acttcaacta       60

cagcagcgat tacagggaca acagcagttg atacaccaaa atcggcaagc tatcttaaac      120

cagtttgcag caactgctcc tgttggcatc aatatgagat caggcatgca acagcaaatt      180

acacctcagc cacccctgaa tgctcaaatg ttggcacaac gtcagcggga actgtacagt      240

caacagcacc gacagaggca gctaatacag cagcaaagag ccatgcttat gaggcagcaa      300

agctttggga acaacctccc tccctcatct ggactatag                             339


<210>  21
<211>  202
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  21

Met Asp Asp Leu Pro Arg Arg Arg Gly Arg Ser Ala Pro Asn Gln Leu 
1               5                   10                  15      


Arg Leu Gln Leu Gln Gln Arg Leu Gln Gly Gln Gln Gln Leu Ile His 
            20                  25                  30          


Gln Asn Arg Gln Ala Ile Leu Asn Gln Phe Ala Ala Thr Ala Pro Val 
        35                  40                  45              


Gly Ile Asn Met Arg Ser Gly Met Gln Gln Gln Ile Thr Pro Gln Pro 
    50                  55                  60                  


Pro Leu Asn Ala Gln Met Leu Ala Gln Arg Gln Arg Glu Leu Tyr Ser 
65                  70                  75                  80  


Gln Gln His Arg Gln Arg Gln Leu Ile Gln Gln Gln Arg Ala Met Leu 
                85                  90                  95      


Met Arg Gln Gln Ser Phe Gly Asn Asn Leu Pro Pro Ser Ser Gly Leu 
            100                 105                 110         


Pro Val Gln Met Gly Asn Pro Arg Leu Pro Gln Gly Ala Pro Gln Gln 
        115                 120                 125             


Phe Pro Tyr Pro Pro Asn Tyr Gly Thr Asn Pro Gly Thr Pro Pro Ala 
    130                 135                 140                 


Ser Thr Ser Pro Phe Ser Gln Leu Ala Ala Asn Pro Glu Ala Ser Leu 
145                 150                 155                 160 


Ala Asn Arg Asn Ser Met Val Ser Arg Gly Met Thr Gly Asn Ile Gly 
                165                 170                 175     


Gly Gln Phe Gly Thr Gly Ile Asn Pro Gln Met Gln Gln Asn Val Phe 
            180                 185                 190         


Gln Tyr Pro Gly Ala Gly Met Val Pro Gln 
        195                 200         


<210>  22
<211>  609
<212>  DNA
<213>  artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  22
atggacgacc tgcccagaag aagaggcaga tccgcaccta accagcttcg acttcaacta       60

cagcagcgat tacagggaca acagcagttg atacaccaaa atcggcaagc tatcttaaac      120

cagtttgcag caactgctcc tgttggcatc aatatgagat caggcatgca acagcaaatt      180

acacctcagc cacccctgaa tgctcaaatg ttggcacaac gtcagcggga actgtacagt      240

caacagcacc gacagaggca gctaatacag cagcaaagag ccatgcttat gaggcagcaa      300

agctttggga acaacctccc tccctcatct ggactaccag ttcaaatggg gaacccccgt      360

cttcctcagg gtgctccaca gcaattcccc tatccaccaa actatggtac aaatccagga      420

accccacctg cttctaccag cccgttttca caactagcag caaatcctga agcatccttg      480

gccaaccgca acagcatggt gagcagaggc atgacaggaa acataggagg acagtttggc      540

actggaatca atcctcagat gcagcagaat gtcttccagt atccaggagc aggaatggtt      600

ccccaatag                                                              609


